Skip to main content
IONS
NASDAQ Life Sciences

Ionis Grants Recordati Ex-US Rights for Zilganersen, Expanding Commercial Reach

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$78.6
Mkt Cap
$12.947B
52W Low
$38.985
52W High
$86.74
52W Position info
102% above low
Off High info
9.4% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

IONS has more than doubled off its 52-week low of $38.985.

Summary

Ionis Pharmaceuticals has granted Recordati ex-US rights to develop and commercialize zilganersen for Alexander disease, while retaining US commercial rights and global development leadership. This partnership expands the potential market for zilganersen, a drug that showed positive pivotal study results in April. The move follows a series of strategic partnerships and positive regulatory news for Ionis, including recent FDA approval for TRYNGOLZA and a licensing deal with Biogen. Analysts also raised their price targets for Ionis, reflecting positive sentiment.

At the time of this announcement, IONS was trading at $78.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.9B. The 52-week trading range was $38.99 to $86.74. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

IONS - Latest Insights

IONS
Nov 17, 2026, 4:45 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $26.93
Real-time Price: $26.76 info
Change: -$0.170 (-0.63%) info
Market Cap: $4.427B info
IONS
Nov 17, 2026, 3:03 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $28.02
Real-time Price: $26.76 info
Change: -$1.26 (-4%) info
Market Cap: $4.427B info
IONS
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $31.17
Real-time Price: $26.76 info
Change: -$4.41 (-14%) info
Market Cap: $4.427B info
IONS
Nov 09, 2026, 11:01 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $28.67
Real-time Price: $26.76 info
Change: -$1.90 (-7%) info
Market Cap: $4.427B info
IONS
Nov 09, 2026, 8:33 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.50
Real-time Price: $26.76 info
Change: -$4.74 (-15%) info
Market Cap: $4.427B info